Editas Medicine, Inc. (EDIT)
Editas Medicine Market Cap : 270.13M for April 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 120.56B |
| ACADIA Pharmaceuticals, Inc. | 3.846B |
| Alnylam Pharmaceuticals, Inc. | 43.40B |
| Savara, Inc. | 1.216B |
| BioMarin Pharmaceutical, Inc. | 11.00B |
Market Cap Related Metrics
| PS Ratio | 6.119 |
| Price to Book Value | 10.03 |
| Price | 2.76 |
| Earnings Yield | -67.38% |